Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vycor MedicalVYCO OCF Margin % is 21.57% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Vycor Medical ranks better than 50.43% on this metric.
The historical rank and industry rank for Vycor Medical's OCF Margin % or its related term are showing as below:
VYCO'
s OCF Margin % Range Over the Past 10 Years
Min: -38.05 Med: -8.97 Max: 3.78
Current: 5.99
During the past 13 years, the highest OCF Margin % of Vycor Medical was 3.78%. The lowest was -38.05%. And the median was -8.97%.
VYCO's OCF Margin % is ranked better than 50.43% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs VYCO: 5.99
Vycor Medical OCF Margin % Related Terms
Vycor Medical OCF Margin % Historical Data
* Premium members only.
The historical data trend for Vycor Medical's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VYCO vs AEMD, VTAK, ALURD: OCF Margin % Comparison
For the Medical Devices subindustry, Vycor Medical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vycor Medical OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Vycor Medical's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical (VYCO) has a OCF Margin % of 21.57% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vycor Medical and its competitors. According to the industry distribution chart, Vycor Medical ranks #404 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 49.6%.
Is Vycor Medical's OCF Margin % too high?
Vycor Medical's current OCF Margin % is 21.57%. The Medical Devices & Instruments industry median OCF Margin % is 5.82. Vycor Medical's value of 21.57% is 270.6% above this industry median. Based on the distribution chart, Vycor Medical ranks #404 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Vycor Medical's OCF Margin % compare to AEMD and VTAK?
According to the Medical Devices & Instruments industry distribution chart, Vycor Medical ranks #404 out of 815 companies for OCF Margin %. This puts Vycor Medical in the upper half of its industry. The industry median OCF Margin % is 5.82. Vycor Medical's value of 21.57% is 270.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vycor Medical's current OCF Margin % of 21.57% is 270.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vycor Medical and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vycor Medical's current OCF Margin % is 21.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vycor Medical stock overvalued right now?
Based on GuruFocus' analysis, Vycor Medical (VYCO) is currently considered Possible Value Trap. The stock's GF Value™ is $0.12, compared to a current price of $0.07 — trading 42.5% below its estimated fair value. The current OCF Margin % is 21.57% and 270.6% above the Medical Devices & Instruments industry median of 5.82. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vycor Medical (VYCO), the current OCF Margin % is 21.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vycor Medical Inc provides the medical community with superior surgical and therapeutic solutions and operates two distinct business units within the medical device industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The company operates in two segments, Vycor Medical and NovaVision, with the majority of the revenue been derived from Vycor Medical segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VYCO has been successfully added to your 
